Lianguo Ruan
- Infectious Diseases top 2%
- Neurology top 5%
- Molecular Biology
- Pharmacology top 5%
- Epidemiology
- Topics
- COVID-19 Clinical Research Studies (9 papers)SARS-CoV-2 and COVID-19 Research (7 papers)Air Quality and Health Impacts (6 papers)
- Partner nations
- ChinaUnited KingdomSwitzerland
In The Last Decade
Lianguo Ruan
28 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 588
- Neurology 212
- Molecular Biology 147
- Pharmacology 147
- Epidemiology 143
Countries citing papers authored by Lianguo Ruan
This map shows the geographic impact of Lianguo Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianguo Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianguo Ruan more than expected).
Fields of papers citing papers by Lianguo Ruan
This network shows the impact of papers produced by Lianguo Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianguo Ruan. The network helps show where Lianguo Ruan may publish in the future.
Co-authorship network of co-authors of Lianguo Ruan
This figure shows the co-authorship network connecting the top 25 collaborators of Lianguo Ruan. A scholar is included among the top collaborators of Lianguo Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianguo Ruan. Lianguo Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 37 | |
| 15 | 9 | |
| 16 | 1 | |
| 17 | 38 | |
| 18 | 7 | |
| 19 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialbreakdown → | 338 |
| 20 | 59 |
About Lianguo Ruan
Lianguo Ruan is a scholar working on Virology, Infectious Diseases and Health, Toxicology and Mutagenesis, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and Air Quality and Health Impacts (6 papers). The work is most often cited by research in Infectious Diseases (588 citations), Pharmacology (147 citations) and Complementary and alternative medicine (135 citations). Lianguo Ruan has collaborated with scholars based in China, United Kingdom and Switzerland. Frequent co-authors include Taisheng Li, Wei Cao, Xiaosheng Liu, Ke Hong, Yang Han, Tao Bai, Hongwei Fan, Ling Lin, Hui Song and Yunting Zhang. Their work appears in journals such as The Science of The Total Environment, Clinical Infectious Diseases and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.